The trial met its primary endpoint, demonstrating that semaglutide 7.2 mg led to significantly greater weight loss at week 72 compared to placebo
The way your body carries weight, responds to the food you eat, and tolerates exercise is hugely influenced by hormones including leptin, cortisol, insulin, estrogen, ghrelin, and of course, Glucagon-Like Peptide-1
Food as medicine, less but better, high protein, more mindful snacking theyre all product positionings that already resonate with consumers, whether or not theyre using GLP-1 drugs
Any decision to combine these approaches should be made in consultation with a healthcare professional who can assess your specific circumstances